Skip to content
The breakthrough Alzheimer’s drug LEQEMBI could receive traditional Food and Drug Administration (FDA) approval later this year after receiving Accelerated Approval in January. Developed […]
Alzheimer’s drug LEQEMBI granted Priority Review for traditional approval Read More »
The planet is drowning in plastics, and the negative impact of plastic pollution is overwhelming. A new report by the Organization for Economic Cooperation
Plastic pollution is getting out of hand — but biotech has solutions Read More »
Cambridge, Massachusetts-based life sciences venture capital company Flagship Pioneering ranked as the No. 5 most innovative company in North America on Fast Company’s prestigious
Flagship Pioneering ranks as the fifth most innovative company for 2023 Read More »
After surviving five mass extinctions, horseshoe crab populations are under pressure—but a regulatory change allowing drug makers to use a synthetic alternative to crabs’
Horseshoe crab population can be spared with regulatory change Read More »
On March 2, 2023, the Biotechnology Innovation Organization (BIO) and 50 other national organizations announced the start of a coalition to advance trust in
BIO joins Coalition for Trust in Health & Science Read More »
Questions regarding the significant profits made by the 340B Drug Pricing Program were raised before the United States Senate Committee on Health, Education, Labor,
Fund tracing shows that a reform of 340B is long overdue Read More »
On Feb. 28, 2023, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended approval for Pfizer’s respiratory
FDA’s advisory panel backs GSK’s RSV vaccine Read More »
The 11th International IP Index was published by the U.S. Chamber of Commerce, highlighting the danger of COVID-19 IP infringement and its potential impact
U.S. Chamber’s IP Index highlights progress and new threats Read More »
Acceligen has developed a breed of pigs resistant to the devastating disease Porcine Reproductive and Respiratory Syndrome (PRRS), the Biotechnology Innovation Organization (BIO) member
Acceligen develops new breed of pigs resistant to PRRS Read More »
The Pfizer RSV vaccine candidate for adults over 60 has been recommended by an advisory committee of the Food and Drug Administration (FDA), and
FDA panel recommends Pfizer RSV vaccine for older adults Read More »
